(EMAILWIRE.COM, April 27, 2010 ) New Delhi, India - As per our latest research report “Indian Healthcare - New Avenues for Growth”, the pharma outsourcing industry in India has been witnessing healthy growth rates for the past few years and is projected to see a CAGR of around 34% during 2010-2013. It has been anticipated that in coming years, the escalation of the industry will continue on the back of growing prospects of the global generics market. Since India remains the leading generic drugs manufacturers globally, the demand for pharma outsourcing will surge as drugs worth billions of dollars are going off-patent in the coming years. We have found that the growth in the pharma outsourcing industry will also be driven by the vast pool of healthcare professionals, who can be recruited at a fraction of costs in India as compared to the costs it takes to recruit them in the West.

Further, low production cost, strong reverse engineering skills, and large number of USFDA-approved manufacturing plants, with a large number of Indian companies upgrading their facilities, will enable India to become a global contract manufacturing hub in near future. Low costs of clinical trials and large patient pool present in the country will pave the way for contract research outsourcing in the country. In our report, we have also evaluated various other factors that will propel the growth of pharma outsourcing market in India over the forecast period (2010-2013).

Besides this, we have done extensive research and prudent analysis of the Indian Healthcare market in order to understand the factors that will continue to push the market growth in future. Growing per capita healthcare spending, epidemiological transitions and shift in the demographic profiles are some of the major factors that have been propelling the growth in the market. The report also gives insight into the role of private players and government initiatives in the growth.

“Indian Healthcare - New Avenues for Growth” provides thorough analysis of the various segments of the healthcare industry like hospital services, pharmaceuticals, medical devices, medical tourism, medical textiles, health insurance, infrastructure, and path labs. It deeply studies each of the industry parameters like key market drivers, emerging sectors in the industry and market restraints. Most importantly, the report gives future outlook for all the important aspects of the industry giving due consideration to the effects of global economic crisis on the base drivers, opportunities and challenges faced by the healthcare industry in the country.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM151.htm

Check DISCOUNTED REPORTS on: http://www.rncos.com

About RNCOS:

RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.

Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.